ArticleThe Journal of clinical endocrinology and metabolism2009

RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.

Marco Volante et al.PubMed ↗Publisher ↗

No numbers read from the abstract.